Pan-cancer analyses reveal regulation and clinical outcome association of the shelterin complex in cancer
Authors:
- 26 January 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 22 (5)
Abstract
Shelterin, a protective complex at telomeres, plays essential roles in cancer. In addition to maintain telomere integrity, shelterin functions in various survival pathways. However, the detailed mechanisms of shelterin regulation in cancer remain elusive. Here, we perform a comprehensive analysis of shelterin in 9125 tumor samples across 33 cancer types using multi-omic data from The Cancer Genome Atlas, and validate some findings in Chinese Glioma Genome Atlas and cancer cell lines from Cancer Cell Line Encyclopedia. In the genomic landscape, we identify the amplification of TRF1 and POT1, co-amplification/deletion of TRF2–RAP1–TPP1 as the dominant alteration events. Clustering analysis based on shelterin expression reveals three cancer clusters with different degree of genome instability. To measure overall shelterin activity in cancer, we derive a shelterin score based on shelterin expression. Pathway analysis shows shelterin is positively correlated with E2F targets, while is negatively correlated with p53 pathway. Importantly, shelterin links to tumor immunity and predicts response to PD-1 blockade immune therapy. In-depth miRNA analysis reveals a miRNA–shelterin interaction network, with p53 regulated miRNAs targeting multiple shelterin components. We also identify a significant amount of lncRNAs regulating shelterin expression. In addition, we find shelterin expression could be used to predict patient survival in 24 cancer types. Finally, by mining the connective map database, we discover a number of potential drugs that might target shelterin. In summary, this study provides broad molecular signatures for further functional and therapeutic studies of shelterin, and also represents a systemic approach to characterize key protein complex in cancer.Keywords
Funding Information
- Guangdong Basic and Applied Basic Research Foundation (2019A1515110832)
- National Natural Science Foundation of China (31900521, 81971305)
This publication has 60 references indexed in Scilit:
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteinsNature Reviews Cancer, 2011
- Positive feedback between p53 and TRF2 during telomere-damage signalling and cellular senescenceNature Cell Biology, 2010
- Elevated TRF2 in advanced breast cancers with short telomeresBreast Cancer Research and Treatment, 2010
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- Telomeres and telomerase in cancerCarcinogenesis, 2009
- The telosome/shelterin complex and its functionsGenome Biology, 2008
- Dysfunctional telomeres activate an ATM‐ATR‐dependent DNA damage response to suppress tumorigenesisThe EMBO Journal, 2007
- Insulin-like growth factor binding protein 2 promotes glioma development and progressionProceedings of the National Academy of Sciences, 2007
- POT1b protects telomeres from end‐to‐end chromosomal fusions and aberrant homologous recombinationThe EMBO Journal, 2006